Helix Biomedix Inc (HXBM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HXBM | AZN | AMGN | GILD | BMY |
| Company | Helix Biomedix Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.7000 | 196.72 | 376.17 | 147.73 | 60.60 |
| High | 1.7000 | 198.09 | 379.26 | 149.37 | 60.96 |
| Low | 1.7000 | 195.37 | 372.74 | 146.84 | 59.98 |
| Latest | 1.7000 | 196.17 | 377.07 | 148.96 | 60.65 |
| Change | -1.0000 | +1.22 | +0.10 | +2.33 | +0.02 |
| % Change | -37.04% | +0.63% | +0.03% | +1.59% | +0.03% |
| Volume | 100 | 999,620 | 1,126,544 | 1,798,391 | 3,862,926 |
| 20-Day Average Volume | N/A | 2,172,177 | 2,602,427 | 7,183,052 | 12,453,709 |
| Previous Close | 2.7000 | 194.95 | 376.97 | 146.63 | 60.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | N/A | 202.93 | 375.87 | 149.41 | 60.91 |
| 20-Day Raw Stochastic | N/A | 28.47% | 53.78% | 40.77% | 39.38% |
| 20-Day Relative Strength | N/A | 49.95 | 57.15 | 56.71 | 57.15 |
| Weighted Alpha | N/A | +32.09 | +29.11 | +41.11 | +15.71 |
| Today's Opinion | N/A | 80% Buy | 100% Buy | 88% Buy | 88% Buy |
| Previous Opinion | N/A | 80% Buy | 100% Buy | 88% Buy | 88% Buy |
| Last Month's Opinion | N/A | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -37.04% since 12/15/25 | -2.85% since 03/03/26 | +0.08% since 03/03/26 | +0.58% since 03/03/26 | -0.90% since 03/03/26 |
| Low | 1.7000 on 03/03/26 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 59.25 on 03/09/26 |
| High | 2.9800 on 02/04/26 | 203.29 on 03/04/26 | 380.09 on 03/04/26 | 149.37 on 03/10/26 | 62.58 on 03/04/26 |
| 1-Month | |||||
| %Chg | -2.86% since 01/23/26 | +1.34% since 02/10/26 | +3.47% since 02/10/26 | +0.99% since 02/10/26 | -0.31% since 02/10/26 |
| Low | 1.7000 on 03/03/26 | 189.35 on 03/09/26 | 361.00 on 02/11/26 | 142.77 on 03/06/26 | 59.23 on 02/19/26 |
| High | 2.9800 on 02/04/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | -39.07% since 11/24/25 | +7.09% since 12/10/25 | +19.63% since 12/10/25 | +22.54% since 12/10/25 | +18.47% since 12/10/25 |
| Low | 1.7000 on 03/03/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.44 on 12/11/25 |
| High | 2.9800 on 02/04/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -62.22% since 08/18/25 | +21.27% since 09/10/25 | +35.47% since 09/10/25 | +29.02% since 09/10/25 | +28.67% since 09/10/25 |
| Low | 1.7000 on 03/03/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 3.9000 on 09/24/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 382 | 302,349,504 | 203,212,464 | 182,029,584 | 123,471,424 |
| Shares Outstanding, K | 225 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 1,890,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -2,480,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | N/A | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | N/A | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.46 | 0.32 | 0.45 | 0.36 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 06/28/14 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.20 | 16.91 | 17.66 | 9.80 |